Novel and Effective Blood‐Based <scp>miRNA</scp> Diagnostic Panel for Gastric Cancer: A Pilot Study in a Japanese Population
GASTROClear demonstrated competent diagnostic efficacy for GC in the detection of GC in our Japanese cohort, even in the early stages of cancer and asymptomatic cases. Its combination with existing serum markers may contribute to efficient risk stratification to detect GC.
Authors
- Naoya Sakamoto (ORCID: https://orcid.org/0000-0001-6273-0189)
- Tatsuro Murano (ORCID: https://orcid.org/0000-0003-0423-2151)
- Lihan Zhou (ORCID: https://orcid.org/0000-0002-1096-2604)
- Tomonori Yano
- Takeshi Kuwata (ORCID: https://orcid.org/0000-0003-0044-953X)
- Ka Yan Chung
- Yew Chung Tang (ORCID: https://orcid.org/0000-0003-0890-7822)
- Jit Kong Cheong (ORCID: https://orcid.org/0000-0002-2658-5436)
- Yuki Kano (ORCID: https://orcid.org/0000-0003-2084-510X)
- Cheng He (ORCID: https://orcid.org/0000-0003-4218-8454)
- Yuan Gao (ORCID: https://orcid.org/0000-0002-6365-7646)
- Ken Takeuchi (ORCID: https://orcid.org/0000-0002-3483-1801)
Institutions
- Taoka Hospital (JP)
- National Cancer Center Hospital East (JP)
- Merck (Singapore) (SG)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/cam4.70790
- Citations
- 4
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Japan Society for the Promotion of Science